{"id":2014,"date":"2026-01-19T17:35:00","date_gmt":"2026-01-19T21:35:00","guid":{"rendered":"https:\/\/sites.nd.edu\/pdnano\/?p=2014"},"modified":"2026-03-04T18:56:45","modified_gmt":"2026-03-04T22:56:45","slug":"our-lab-at-notre-dame-receives-notice-of-allowance-for-novel-nanoparticle-immunotherapy-technology","status":"publish","type":"post","link":"https:\/\/sites.nd.edu\/pdnano\/?p=2014","title":{"rendered":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology"},"content":{"rendered":"\n

The patent office has officially issued a Notice of Allowance for Application US 18\/547,664, marking a significant step forward in the fight against cancer. The technology, developed by Prakash Nallathamby<\/strong> and the research team, introduces a novel approach utilizing “Bispecific bridge nanoparticles.”<\/strong><\/p>\n\n\n\n

Bridging the Gap in Cancer Treatment<\/strong> Current challenges in cancer therapy often revolve around targeting mechanisms. This newly allowed patent protects a method that utilizes nanoparticles to serve as a “bridge,” facilitating efficient targeting for:<\/p>\n\n\n\n

    \n
  1. Universal CAR-T Cell Therapy:<\/strong> Allowing T-cells to recognize and attack cancer cells more universally.<\/li>\n\n\n\n
  2. Targeted Chemotherapy:<\/strong> Improving the precision of drug delivery.<\/li>\n<\/ol>\n\n\n\n

    Next Steps<\/strong> The University of Notre Dame\u2019s IDEA Center<\/strong>, led by Intellectual Property Manager Carrie Jennings, is finalizing the administrative steps, with the official patent expected to issue shortly after April 20th.<\/p>\n\n\n\n

    This allowance validates the novelty of the team’s work and paves the way for commercialization and future clinical applications.<\/p>\n\n\n\n

    Science #CancerCure #NotreDame #Biotech #Patented<\/p>\n","protected":false},"excerpt":{"rendered":"

    The patent office has officially issued a Notice of Allowance for Application US 18\/547,664, marking a significant step forward in the fight against cancer. The technology, developed by Prakash Nallathamby and the research team, introduces a novel approach utilizing “Bispecific bridge nanoparticles.” Bridging the Gap in Cancer Treatment Current challenges in cancer therapy often revolve … <\/p>\n

    Continue reading »<\/a><\/p>\n","protected":false},"author":2672,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[405092,405087],"class_list":["post-2014","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-berthiaume-institute-for-precision-health","tag-biomimetic-2"],"yoast_head":"\nOur Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.nd.edu\/pdnano\/?p=2014\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory\" \/>\n<meta property=\"og:description\" content=\"The patent office has officially issued a Notice of Allowance for Application US 18\/547,664, marking a significant step forward in the fight against cancer. The technology, developed by Prakash Nallathamby and the research team, introduces a novel approach utilizing “Bispecific bridge nanoparticles.” Bridging the Gap in Cancer Treatment Current challenges in cancer therapy often revolve … Continue reading »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.nd.edu\/pdnano\/?p=2014\" \/>\n<meta property=\"og:site_name\" content=\"Nallathamby Laboratory\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prakashdn\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-19T21:35:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-04T22:56:45+00:00\" \/>\n<meta name=\"author\" content=\"Prakash\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prakashdn\" \/>\n<meta name=\"twitter:site\" content=\"@prakashdn\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prakash\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014\"},\"author\":{\"name\":\"Prakash\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\"},\"headline\":\"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology\",\"datePublished\":\"2026-01-19T21:35:00+00:00\",\"dateModified\":\"2026-03-04T22:56:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014\"},\"wordCount\":171,\"keywords\":[\"Berthiaume Institute for Precision Health\",\"biomimetic\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014\",\"name\":\"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#website\"},\"datePublished\":\"2026-01-19T21:35:00+00:00\",\"dateModified\":\"2026-03-04T22:56:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2014#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#website\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/\",\"name\":\"Modular Nanotechnologies and Nanomaterials\",\"description\":\"Modular and scalable nanotechnology for imaging, sensing and therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\",\"name\":\"Prakash\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?author=2672\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.nd.edu\/pdnano\/?p=2014","og_locale":"en_US","og_type":"article","og_title":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory","og_description":"The patent office has officially issued a Notice of Allowance for Application US 18\/547,664, marking a significant step forward in the fight against cancer. The technology, developed by Prakash Nallathamby and the research team, introduces a novel approach utilizing “Bispecific bridge nanoparticles.” Bridging the Gap in Cancer Treatment Current challenges in cancer therapy often revolve … Continue reading »","og_url":"https:\/\/sites.nd.edu\/pdnano\/?p=2014","og_site_name":"Nallathamby Laboratory","article_publisher":"https:\/\/www.facebook.com\/prakashdn","article_published_time":"2026-01-19T21:35:00+00:00","article_modified_time":"2026-03-04T22:56:45+00:00","author":"Prakash","twitter_card":"summary_large_image","twitter_creator":"@prakashdn","twitter_site":"@prakashdn","twitter_misc":{"Written by":"Prakash","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014#article","isPartOf":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014"},"author":{"name":"Prakash","@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0"},"headline":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology","datePublished":"2026-01-19T21:35:00+00:00","dateModified":"2026-03-04T22:56:45+00:00","mainEntityOfPage":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014"},"wordCount":171,"keywords":["Berthiaume Institute for Precision Health","biomimetic"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014","url":"https:\/\/sites.nd.edu\/pdnano\/?p=2014","name":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology - Nallathamby Laboratory","isPartOf":{"@id":"https:\/\/sites.nd.edu\/pdnano\/#website"},"datePublished":"2026-01-19T21:35:00+00:00","dateModified":"2026-03-04T22:56:45+00:00","author":{"@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0"},"breadcrumb":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.nd.edu\/pdnano\/?p=2014"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2014#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.nd.edu\/pdnano\/"},{"@type":"ListItem","position":2,"name":"Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology"}]},{"@type":"WebSite","@id":"https:\/\/sites.nd.edu\/pdnano\/#website","url":"https:\/\/sites.nd.edu\/pdnano\/","name":"Modular Nanotechnologies and Nanomaterials","description":"Modular and scalable nanotechnology for imaging, sensing and therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.nd.edu\/pdnano\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0","name":"Prakash","url":"https:\/\/sites.nd.edu\/pdnano\/?author=2672"}]}},"_links":{"self":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/users\/2672"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2014"}],"version-history":[{"count":3,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2014\/revisions"}],"predecessor-version":[{"id":2034,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2014\/revisions\/2034"}],"wp:attachment":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}